$Histogenics(OCGN)$ 你买了吗？INDIA NEWSHopefully 'soon': Niti Aayog's VK Paul on WHO emergency approval for CovaxinThe lack of endorsement from WHO has been hampering travel plans for individuals as many countries are only accepting vaccines approved by the public health body.By hindustantimes.com, Hindustan Times, New DelhiUPDATED ON JUN 28, 2021 07:12 PM ISTA healthcare worker fills a syringe with a dose of Bharat Biotech's Covid-19 vaccine called Covaxin, during the coronavirus disease (Covid-19) vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi.(REUTERS)The process for getting Covaxin’s Emergency Use Listing (EUL) authorisation by the World Health Organisation (WHO) is proceeding very well, Dr VK Paul,

$AMC Entertainment(AMC)$ should be 30% Gain not the issue 

$Histogenics(OCGN)$ Good New for OCGN pre market was 12%. Will it 20cm.[开心] 

（日内瓦、华盛顿6日讯）美国政府当地时间周三宣布，支持在新冠肺炎疫情大流行期间，暂停保护疫苗的专利权，世界卫生组织（WHO）大表赞扬，形容是历史性决定，造福世人。与此同时，美国两大药厂则表示反对。世卫总干事谭德塞赞扬这是“历史性决定”，是朝着实现疫苗公平迈出的一步，“在关键时刻优先考虑到世界各地所有人的福祉”。去年10月，印度和南非在世界贸易组织（WTO）上提出一项措施，要求容许各国暂时不顾疫症相关医疗产品的专利权，此建议其后得到近60个国家的支持。美国前总统特朗普政府当时与英国、欧盟和瑞士坚决反对这项豁免措施，但拜登政府上台后却重新审视这一立场，震惊了美国制药公司。路透社报导，拜登这是屈服于民主党议员和上百个世界国家的压力，激怒制药大厂。美国财经媒体CNBC报导，美国制药协会主席乌比警告，拜登政府此举将造成混乱，弱化已经吃紧的供应链，并促进伪疫苗盛行。消息传出后，美国最大的两间疫苗生产商辉瑞（Pfizer）及莫德纳（Moderna）股票也都应声下跌，两家药厂也对官方说法表示反弹。CNBC报导，辉瑞平盘作收，莫德纳跌幅6.1%，强生（Johnson & Johnson）小跌0.4%

$BioNTech SE(BNTX)$ 48day to go for Q2 report announcements. Prepare buy some to hold. [微笑] 

$Tecnoglass(TGLS)$ Price will go up back the incorrect information report by H.